TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Acustimulation Attenuate Postoperative Nausea and Vomiting in Children Who Have Undergone Tonsillectomy/Adenoidectomy?
Brief Summary: Postoperative nausea and vomiting (PONV) remain a significant challenge in the investigators practice. However, pharmaceutical prophylaxis can imply unpleasant adverse effects. It would therefore be appropriate to consider the use of non-pharmacological methods in preventing PONV. Acupuncture and acupressure are reported to be effective preventive treatment for PONV, and the adverse effects are minimal.

Consequently, the investigators will investigate if acupuncture and acupressure can be implemented as a supplementary to the ordinary treatment in children undergoing surgery for tonsillectomy and/or adenoidectomy. The study will also focus on the feasibility for acupuncture and acupressure in the operation theatre. The study and inclusion/exclusion decisions are conducted after the "intention-to-treat" principle. 126 patients are included, divided into two groups:

1. Treatment Group - standard treatment and acupuncture performed after induction of anaesthesia, acupressure administered before awakening
2. Control Group - standard treatment

The primarily endpoints in this study are nausea, retching and vomiting. The effect of acupuncture/acupressure will be studied with regard to any association with possible factors of predisposition to PONV, as well as with other factors registered during the study. Adverse effects from the acupuncture site and wristband will be registered.


Options:
A: Arm Label: Acustimulation; Type: EXPERIMENTAL; Interventions: Device: Acustimulation | Arm Label: Standard treatment group; Type: NO_INTERVENTION; Interventions: Device: Acustimulation | Intervention Type: DEVICE; Name: Acustimulation; Assigned to Arm(s): Acustimulation, Standard treatment group
B: Intervention Type: DEVICE; Name: Vital-band (R); Assigned to Arm(s): N/A
C: Intervention Type: DEVICE; Name: Acupressure; Assigned to Arm(s): N/A
D: Arm Label: P6 acupressure group; Type: ACTIVE_COMPARATOR; Interventions: Device: P6 acupressure band | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo band | Intervention Type: DEVICE; Name: P6 acupressure band; Assigned to Arm(s): P6 acupressure group | Intervention Type: OTHER; Name: Placebo band; Assigned to Arm(s): Placebo group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia
Brief Summary: The investigators are doing this study to better understand the role of the central nervous system in processing painful stimuli in patients with fibromyalgia. Specifically, the investigators would like to know whether the central nervous system processing of painful stimuli changes with time and with talk therapy. In addition, the investigators are investigating how changes in your fibromyalgia symptoms may affect certain markers or proteins in your blood.


Options:
A: Arm Label: CBT and milnacipran; Type: EXPERIMENTAL; Interventions: Other: CBT and milnacipran | Arm Label: CBT and placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: CBT with a placebo | Arm Label: Educational with milnacipran; Type: ACTIVE_COMPARATOR; Interventions: Drug: Educational with milnacipran | Intervention Type: OTHER; Name: CBT and milnacipran; Assigned to Arm(s): CBT and milnacipran | Intervention Type: BEHAVIORAL; Name: CBT with a placebo; Assigned to Arm(s): CBT and placebo | Intervention Type: DRUG; Name: Educational with milnacipran; Assigned to Arm(s): Educational with milnacipran
B: Arm Label: CTB Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CTB Group
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducative program in fibromyalgic patients | Intervention Type: BEHAVIORAL; Name: Psychoeducative program in fibromyalgic patients; Assigned to Arm(s): 1
D: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Prospective Trial of Metformin Compared to Glyburide in Gestational Diabetes
Brief Summary: Our hypothesis is that metformin and glyburide will have equal efficacy in controlling blood glucose in gestational diabetics with no increase in adverse maternal, fetal or neonatal outcomes.


Options:
A: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin | Arm Label: Glyburide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glyburide | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Glyburide; Assigned to Arm(s): Glyburide
B: Arm Label: Nutritional counseling & self blood glucose monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: nutritional counseling, Behavioral: self blood glucose monitoring | Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: nutritional counseling; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring | Intervention Type: BEHAVIORAL; Name: self blood glucose monitoring; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring
C: Arm Label: Glyburide (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Insulin (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Metformin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Insulin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Metformin (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Arm Label: Glyburide (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Intervention Type: DRUG; Name: Glyburide vs Insulin trials; Assigned to Arm(s): Glyburide (Glyburide vs Insulin), Insulin (Glyburide vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Insulin trials; Assigned to Arm(s): Insulin (Metformin vs Insulin), Metformin (Metformin vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Glyburide trials; Assigned to Arm(s): Glyburide (Metformin vs Glyburide), Metformin (Metformin vs Glyburide)
D: Arm Label: Glyburide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glyburide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Glyburide; Assigned to Arm(s): Glyburide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Study of YM178 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients With Overactive Bladder
Brief Summary: The purpose of the study is to evaluate the effect of YM178 in patients with overactive bladder for 12-week administration.


Options:
A: Arm Label: YM178 group; Type: EXPERIMENTAL; Interventions: Drug: YM178 | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: tolterodine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: tolterodine | Intervention Type: DRUG; Name: YM178; Assigned to Arm(s): YM178 group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo group | Intervention Type: DRUG; Name: tolterodine; Assigned to Arm(s): tolterodine group
B: Arm Label: Vibegron + Placebo to match Tolterodine; Type: EXPERIMENTAL; Interventions: Drug: vibegron, Drug: Tolterodine placebo | Arm Label: Placebo to match vibegron + Placebo to match Tolterodine; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vibegron placebo, Drug: Tolterodine placebo | Arm Label: Tolterodine + Placebo to match vibegron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vibegron placebo, Drug: Tolterodine Tartrate ER | Intervention Type: DRUG; Name: vibegron; Assigned to Arm(s): Vibegron + Placebo to match Tolterodine | Intervention Type: DRUG; Name: Vibegron placebo; Assigned to Arm(s): Placebo to match vibegron + Placebo to match Tolterodine, Tolterodine + Placebo to match vibegron | Intervention Type: DRUG; Name: Tolterodine Tartrate ER; Assigned to Arm(s): Tolterodine + Placebo to match vibegron | Intervention Type: DRUG; Name: Tolterodine placebo; Assigned to Arm(s): Placebo to match vibegron + Placebo to match Tolterodine, Vibegron + Placebo to match Tolterodine
C: Intervention Type: DRUG; Name: ONO-8025 (KRP-197); Assigned to Arm(s): N/A
D: Arm Label: Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Solifenacin Succinate; Type: EXPERIMENTAL; Interventions: Drug: Solifenacin Succinate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): Solifenacin Succinate

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients Undergoing Chemotherapy Treatment.
Brief Summary: The goal of this clinical research study is to learn if dalteparin can lower the risk of VTE occurring in the legs and lungs. This will be tested in patients with pancreatic cancer who are going to receive chemotherapy. Some patients will receive dalteparin and some will receive no study drug.

The safety of dalteparin will also be studied.


Options:
A: Arm Label: Group 1: Dalteparin; Type: EXPERIMENTAL; Interventions: Drug: Dalteparin | Arm Label: Group 2: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Dalteparin; Assigned to Arm(s): Group 1: Dalteparin
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks | Intervention Type: DRUG; Name: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks; Assigned to Arm(s): A, B
C: Arm Label: chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chemotherapy at the investigator's discretion | Arm Label: dalteparin; Type: EXPERIMENTAL; Interventions: Drug: daltéparine, Drug: Chemotherapy at the investigator's discretion | Intervention Type: DRUG; Name: daltéparine; Assigned to Arm(s): dalteparin | Intervention Type: DRUG; Name: Chemotherapy at the investigator's discretion; Assigned to Arm(s): chemotherapy, dalteparin
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Bemiparin | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Bemiparin; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients Undergoing Chemotherapy Treatment.
Brief Summary: The goal of this clinical research study is to learn if dalteparin can lower the risk of VTE occurring in the legs and lungs. This will be tested in patients with pancreatic cancer who are going to receive chemotherapy. Some patients will receive dalteparin and some will receive no study drug.

The safety of dalteparin will also be studied.


Options:
A: Arm Label: Group 1: Dalteparin; Type: EXPERIMENTAL; Interventions: Drug: Dalteparin | Arm Label: Group 2: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Dalteparin; Assigned to Arm(s): Group 1: Dalteparin
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lenalidomide, Drug: Prednisone, Drug: Melphalan | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Melphalan | Intervention Type: DRUG; Name: Melphalan; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Lenalidomide; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Melphalan; Assigned to Arm(s): A
C: Arm Label: saline solution; Type: PLACEBO_COMPARATOR; Interventions: Drug: saline solution (placebo) | Arm Label: nadroparin calcium; Type: EXPERIMENTAL; Interventions: Drug: Nadroparin calcium | Intervention Type: DRUG; Name: Nadroparin calcium; Assigned to Arm(s): nadroparin calcium | Intervention Type: DRUG; Name: saline solution (placebo); Assigned to Arm(s): saline solution
D: Arm Label: Semuloparin; Type: EXPERIMENTAL; Interventions: Drug: Semuloparin sodium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for semuloparin) | Intervention Type: DRUG; Name: Semuloparin sodium; Assigned to Arm(s): Semuloparin | Intervention Type: DRUG; Name: Placebo (for semuloparin); Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Scientific Evaluation of a Cash Transfer Pilot Project to Support Orphans and Vulnerable Children (OVC) in Manicaland, Zimbabwe
Brief Summary: The purpose of this study is to determine whether cash transfers (conditional and unconditional) can improve health and social outcomes amongst children living in vulnerable households in Manicaland, eastern Zimbabwe. The study hypotheses are:

1. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with a birth certificate.
2. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with up-to-date vaccinations.
3. Cash transfers will increase the percentage of vulnerable children aged 6-12 years attending primary school at least 80% of days per month.


Options:
A: Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Sulfadoxine pyrimethamine; Assigned to Arm(s): N/A
C: Arm Label: Conditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Conditional Cash Transfer, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Unconditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Unconditional Cash Transfers, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Control; Type: OTHER; Interventions: Other: Standard Agricultural Package, Other: Parenting Skills Classes | Intervention Type: OTHER; Name: Conditional Cash Transfer; Assigned to Arm(s): Conditional Cash Transfer | Intervention Type: OTHER; Name: Unconditional Cash Transfers; Assigned to Arm(s): Unconditional Cash Transfer | Intervention Type: OTHER; Name: Standard Agricultural Package; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer | Intervention Type: OTHER; Name: Parenting Skills Classes; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer
D: Arm Label: mailed reminder notice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mailed influenza vaccination reminder notice | Arm Label: No reminder notice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mailed influenza vaccination reminder notice; Assigned to Arm(s): mailed reminder notice

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Scientific Evaluation of a Cash Transfer Pilot Project to Support Orphans and Vulnerable Children (OVC) in Manicaland, Zimbabwe
Brief Summary: The purpose of this study is to determine whether cash transfers (conditional and unconditional) can improve health and social outcomes amongst children living in vulnerable households in Manicaland, eastern Zimbabwe. The study hypotheses are:

1. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with a birth certificate.
2. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with up-to-date vaccinations.
3. Cash transfers will increase the percentage of vulnerable children aged 6-12 years attending primary school at least 80% of days per month.


Options:
A: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
B: Arm Label: Conditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Conditional Cash Transfer, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Unconditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Unconditional Cash Transfers, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Control; Type: OTHER; Interventions: Other: Standard Agricultural Package, Other: Parenting Skills Classes | Intervention Type: OTHER; Name: Conditional Cash Transfer; Assigned to Arm(s): Conditional Cash Transfer | Intervention Type: OTHER; Name: Unconditional Cash Transfers; Assigned to Arm(s): Unconditional Cash Transfer | Intervention Type: OTHER; Name: Standard Agricultural Package; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer | Intervention Type: OTHER; Name: Parenting Skills Classes; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive
D: Arm Label: Two-way SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Two-way SMS | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Two-way SMS; Assigned to Arm(s): Two-way SMS

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Scientific Evaluation of a Cash Transfer Pilot Project to Support Orphans and Vulnerable Children (OVC) in Manicaland, Zimbabwe
Brief Summary: The purpose of this study is to determine whether cash transfers (conditional and unconditional) can improve health and social outcomes amongst children living in vulnerable households in Manicaland, eastern Zimbabwe. The study hypotheses are:

1. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with a birth certificate.
2. Cash transfers will increase the percentage of vulnerable children aged 0-4 years with up-to-date vaccinations.
3. Cash transfers will increase the percentage of vulnerable children aged 6-12 years attending primary school at least 80% of days per month.


Options:
A: Arm Label: Conditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Conditional Cash Transfer, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Unconditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Unconditional Cash Transfers, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Control; Type: OTHER; Interventions: Other: Standard Agricultural Package, Other: Parenting Skills Classes | Intervention Type: OTHER; Name: Conditional Cash Transfer; Assigned to Arm(s): Conditional Cash Transfer | Intervention Type: OTHER; Name: Unconditional Cash Transfers; Assigned to Arm(s): Unconditional Cash Transfer | Intervention Type: OTHER; Name: Standard Agricultural Package; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer | Intervention Type: OTHER; Name: Parenting Skills Classes; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer
B: Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Sulfadoxine pyrimethamine; Assigned to Arm(s): N/A
D: Arm Label: SMS Vaccine; Type: N/A; Interventions: Behavioral: SMS message reminding mothers to come for their scheduled vaccines | Arm Label: Usual care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS message reminding mothers to come for their scheduled vaccines; Assigned to Arm(s): SMS Vaccine

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Propranolol vs Prednisolone for Infant Hemangiomas-A Clinical and Molecular Study
Brief Summary: Hemangiomas are relatively common lesions in infants. Most go away spontaneously after one year of life and do not need treatment. Others require treatment because they cause significant symptoms such as pain, or difficulty with breathing, eating or ambulating. Steroids have classically been used to treat hemangiomas and help to shrink them in 1/3 - 2/3 of patients. Unfortunately, steroids have many side effects in babies so physicians have sought other ways to treat them. Recently, the use of propranolol, a heart medication, was serendipitously found to reduce the size of hemangiomas. It appears to have many fewer side effects than steroids but it is not yet known if it works as well as steroids. This study seeks to compare the effect and the side effects of propranolol versus steroids for treating hemangiomas that cause symptoms in infants.


Options:
A: Arm Label: Propranolol oral solution; Type: EXPERIMENTAL; Interventions: Drug: Propranolol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Propranolol; Assigned to Arm(s): Propranolol oral solution | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Imiquimod 5% cream; Assigned to Arm(s): N/A
C: Arm Label: Cryocontact therapy; Type: EXPERIMENTAL; Interventions: Procedure: cryocontact therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Procedure: cryocontact therapy, Other: Control | Intervention Type: PROCEDURE; Name: cryocontact therapy; Assigned to Arm(s): Control, Cryocontact therapy | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: propranolol for treatment of hemangiomas; Type: EXPERIMENTAL; Interventions: Drug: propranolol | Arm Label: Prednisolone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prednisolone | Intervention Type: DRUG; Name: propranolol; Assigned to Arm(s): propranolol for treatment of hemangiomas | Intervention Type: DRUG; Name: Prednisolone; Assigned to Arm(s): Prednisolone

Answer: D